Marcela M. Cordero Garcia

Array ( [id] => 5993485 [patent_doc_number] => 20110015138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'INHIBITION OF INFLAMMATION USING ANTAGONISTS OF MUC1' [patent_app_type] => utility [patent_app_number] => 12/789127 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 25467 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015138.pdf [firstpage_image] =>[orig_patent_app_number] => 12789127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713265 [patent_doc_number] => 08399406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)' [patent_app_type] => utility [patent_app_number] => 12/788480 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5513 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12788480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144477 [patent_doc_number] => 20110130333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID' [patent_app_type] => utility [patent_app_number] => 12/786845 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6643 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130333.pdf [firstpage_image] =>[orig_patent_app_number] => 12786845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6566865 [patent_doc_number] => 20100234299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'STABLE FORMULATION OF MODIFIED GLP-1' [patent_app_type] => utility [patent_app_number] => 12/785861 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19913 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234299.pdf [firstpage_image] =>[orig_patent_app_number] => 12785861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495342 [patent_doc_number] => 20100286063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'GNRH agonist combination drugs' [patent_app_type] => utility [patent_app_number] => 12/662866 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16146 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286063.pdf [firstpage_image] =>[orig_patent_app_number] => 12662866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8405554 [patent_doc_number] => 20120237614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'PEPTIDE ABLE TO DISRUPT THE PROTEIN COMPLEX BETWEEN THE HIS273 MUTADED P53 PROTEIN AND THE ONCOSUPPRESSIVE P73 PROTEIN IN TUMOR CELLS AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/319682 [patent_app_country] => US [patent_app_date] => 2010-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4107 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6579508 [patent_doc_number] => 20100273981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Use of Silintaphin for the Structure-Directed Fabrication of (Nano)Composite Materials in Medicine and (Nano)Technology' [patent_app_type] => utility [patent_app_number] => 12/768257 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10420 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273981.pdf [firstpage_image] =>[orig_patent_app_number] => 12768257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11277002 [patent_doc_number] => 09493477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof' [patent_app_type] => utility [patent_app_number] => 13/393470 [patent_app_country] => US [patent_app_date] => 2010-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 20 [patent_no_of_words] => 56118 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778255 [patent_doc_number] => 20120040898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/264687 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12511 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040898.pdf [firstpage_image] =>[orig_patent_app_number] => 13264687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577892 [patent_doc_number] => 08344102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Nanoparticle and magnetic resonance imaging contrast agent' [patent_app_type] => utility [patent_app_number] => 12/760396 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4554 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12760396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234853 [patent_doc_number] => 20100266557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'NOVEL PEPTIDE-BASED SCAFFOLDS FOR CARTILAGE REGENERATION AND METHODS FOR THEIR USE' [patent_app_type] => utility [patent_app_number] => 12/759683 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14476 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266557.pdf [firstpage_image] =>[orig_patent_app_number] => 12759683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555405 [patent_doc_number] => 08329877 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Methods for separating recombinant proteins in aqueous two-phase systems' [patent_app_type] => utility [patent_app_number] => 12/723356 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7049 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12723356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10594732 [patent_doc_number] => 09315808 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-19 [patent_title] => 'Cell-specifically effective molecules on the basis of siRNA and application kits for the production thereof and use thereof' [patent_app_type] => utility [patent_app_number] => 13/255033 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 3014 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670078 [patent_doc_number] => 20110319347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'ANTIOXIDANT AGENT' [patent_app_type] => utility [patent_app_number] => 13/255551 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8500 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6508005 [patent_doc_number] => 20100216250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Methods for Predicting Trisomy 21 in a Fetus' [patent_app_type] => utility [patent_app_number] => 12/710062 [patent_app_country] => US [patent_app_date] => 2010-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 37029 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216250.pdf [firstpage_image] =>[orig_patent_app_number] => 12710062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909420 [patent_doc_number] => 08481483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Cyclosporin analogues' [patent_app_type] => utility [patent_app_number] => 12/708671 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17939 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12708671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909420 [patent_doc_number] => 08481483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Cyclosporin analogues' [patent_app_type] => utility [patent_app_number] => 12/708671 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17939 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12708671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11749228 [patent_doc_number] => 09707227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Treatment of T-cell mediated diseases' [patent_app_type] => utility [patent_app_number] => 12/707942 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9969 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12707942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549464 [patent_doc_number] => 08324347 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry' [patent_app_type] => utility [patent_app_number] => 12/707137 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 10812 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12707137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657292 [patent_doc_number] => 20110306561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'COMPLEMENT C3a DERIVED DIMERIC PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/148950 [patent_app_country] => US [patent_app_date] => 2010-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16066 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306561.pdf [firstpage_image] =>[orig_patent_app_number] => 13148950 [rel_patent_id] =>[rel_patent_doc_number] =>)